Finance

Lists
CGTX:NASDAQ
Cognition Therapeutics Inc
1,04 US$
+2,48%
(+0,025) 1D
15 სექ, 15:01:54 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CGTX...
Open
1,00 US$
High
1,04 US$
Low
0,98 US$
Mkt. cap
98,42 მლნ.
Avg. vol.
475,74 ათ.
Volume
433,92 ათ.
52-wk high
2,05 US$
52-wk low
0,55 US$
EPS
-0,20 US$
Beta
1,79
Shares outstanding
95,09 მლნ.
No. of employees
14
Open
1,00 US$
High
1,04 US$
Low
0,98 US$
Mkt. cap
98,42 მლნ.
Avg. vol.
475,74 ათ.
Volume
433,92 ათ.
52-wk high
2,05 US$
52-wk low
0,55 US$
EPS
-0,20 US$
Beta
1,79
Shares outstanding
95,09 მლნ.
No. of employees
14
News stories
From web sources and news partners
About Cognition Therapeutics Inc
CEO-
Employees14
Founded1 იან. 2007
Headquarters-
SectorPharmaceutical industry
Websitecogrx.com
Analyst ratings
Based on 1 analyst giving stock ratings to CGTX in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for CGTX in the last 3 months
Highest
Current 1,04 US$
3,00 US$ (+189,86%)
Average
3,00 US$ (+189,86%)
Lowest
3,00 US$ (+189,86%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
3,00 US$
+189,9%
08/13/2026
Daniil Gataulin
Chardan Capital
Buy
Reiterated
4,00 US$
+286,5%
05/08/2026
William Wood
B. Riley Securities
Buy
Maintained
3,00 US$
+189,9%
11/21/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3,77 მლნ.
11,15 მლნ.
6,12 მლნ.
5,10 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,60 მლნ.
2,52 მლნ.
2,70 მლნ.
2,64 მლნ.
Operating expense
6,38 მლნ.
13,67 მლნ.
8,82 მლნ.
7,74 მლნ.
Total operating expenses
6,38 მლნ.
13,67 მლნ.
8,82 მლნ.
7,74 მლნ.
Operating income
-6,38 მლნ.
-13,67 მლნ.
-8,82 მლნ.
-7,74 მლნ.
Other non operating income
1,44 მლნ.
10,33 მლნ.
4,25 მლნ.
3,81 მლნ.
EBT including unusual items
-4,93 მლნ.
-3,34 მლნ.
-4,57 მლნ.
-3,93 მლნ.
EBT excluding unusual items
-4,93 მლნ.
-3,34 მლნ.
-4,57 მლნ.
-3,93 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4,93 მლნ.
-3,34 მლნ.
-4,57 მლნ.
-3,93 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-0,06
-0,02
-0,05
-0,04
Interest and investment income
-
-
-
-
Interest expense
-
-5,00 ათ.
-5,00 ათ.
-3,00 ათ.
Net interest expenses
-
-5,00 ათ.
-5,00 ათ.
-3,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-6,36 მლნ.
-13,66 მლნ.
-8,81 მლნ.
-7,73 მლნ.
Gain or loss from assets sale
-
41,00 ათ.
5,00 ათ.
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები